Department of Hematology and Medical Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.
Front Immunol. 2022 Apr 20;13:872010. doi: 10.3389/fimmu.2022.872010. eCollection 2022.
Cytokines regulate both the innate and adaptive immune responses to cancer. Although antitumor activity has been seen for several cytokines in preclinical models, they have had limited success as single therapeutic agents in clinical trials of cancer immunotherapy. However, the possible combinations of cytokines with other immune therapeutics and the advancement in genetic engineering, synthetic biology and cellular and immune therapy has led to the revival of interest in cytokines as anticancer agents. This article will review several immunostimulatory cytokines with anticancer activity, focusing on the those that have been studied in treatment of lymphoma and highlighting recent advances of potential clinical relevance.
细胞因子调节着癌症的固有免疫和适应性免疫反应。虽然几种细胞因子在临床前模型中表现出抗肿瘤活性，但作为癌症免疫治疗临床试验中的单一治疗药物，它们的效果有限。然而，细胞因子与其他免疫疗法的可能组合以及遗传工程、合成生物学和细胞与免疫治疗的进步，使得人们重新对细胞因子作为抗癌药物产生了兴趣。本文将综述几种具有抗肿瘤活性的免疫刺激细胞因子，重点介绍那些已在淋巴瘤治疗中进行研究的细胞因子，并强调具有潜在临床相关性的最新进展。
